Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female|Ovarian Cancer|Gastric Cancer
Interventions: BIOLOGICAL: Nivolumab|BIOLOGICAL: Ipilimumab
Sponsor: ExcellaBio LLC